ROcardia s.r.o.

This site is focused on cardiovascular diseases, with clinical research centered on major conditions such as atherosclerotic cardiovascular disease and atrial fibrillation. The trials are designed to assess whether new or emerging treatments can better prevent serious heart- and stroke-related events.

• Studies in atrial fibrillation are evaluating approaches to reduce the risk of stroke and other clot-related complications.
• Research in atherosclerotic cardiovascular disease is examining whether treatment can lower the chance of cardiovascular death, heart attack, or ischemic stroke.

Overall, the research at this hospital/clinic site in Prostejov is aimed at improving prevention and treatment strategies for people at risk of major cardiovascular events.